China rolls out first one-jab COVID-19 vaccine, rival to US’s Johnson & Johnson

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator. China's first Ad5-nCoV COVID-19 vaccine was rolled out on Friday, as per state-run media reports.